Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis
Clinical trial NCT03233230 · COMPLETED
Trial details
- NCT number
- NCT03233230
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-18
- Primary completion
- 2019-09-23
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.